Scientists and clinicians test their metal–back to the future with platinum compounds
- 1 May 2002
- journal article
- Published by Elsevier in The Lancet Oncology
- Vol. 3 (5) , 312-318
- https://doi.org/10.1016/s1470-2045(02)00733-7
Abstract
No abstract availableKeywords
This publication has 70 references indexed in Scilit:
- Lessons learned from BRCA1 and BRCA2Oncogene, 2000
- Roles of BRCA1 and its interacting proteinsBioEssays, 2000
- A Sense of the EndScience, 2000
- The Efficiency and Fidelity of Translesion Synthesis past Cisplatin and Oxaliplatin GpG Adducts by Human DNA Polymerase βJournal of Biological Chemistry, 2000
- A gene expression database for the molecular pharmacology of cancerNature Genetics, 2000
- Review: ATM: the protein encoded by the gene mutated in the radiosensitive syndrome ataxia-telangiectasiaInternational Journal of Radiation Biology, 1999
- Inhibition of telomerase increases the susceptibility of human malignant glioblastoma cells to cisplatin-induced apoptosisOncogene, 1998
- Disruption of DNA-PK in Ku80 mutant xrs-6 and the implications in DNA double-strand break repairMutation Research/DNA Repair, 1996
- Transcription-Coupled Repair and Human DiseaseScience, 1994
- Mechanisms of cisplatin (cis-diamminodichloroplatinum II)-induced cytotoxicity and genotoxicity in yeastMutation Research - Fundamental and Molecular Mechanisms of Mutagenesis, 1984